Skip to main content

Tweets

Cabaletta Bio announced FDA has granted Orphan Drug Designation to CABA-201, a 4-1BB-containing human CD19-CAR T cell agent, to treat systemic sclerosis. RESET (REstoring SElf-Tolerance) trial program includes the Phase 1/2 RESET-SSc trial https://t.co/SWAwLs4PzG https://t.co/3yJ8zlhN9C
Dr. John Cush @RheumNow ( View Tweet )
1 year 10 months ago
Norwegian Institute of Public Health found that among more than 10,000 adults, those who were physically active had a higher pain tolerance than those who were sedentary; and the higher the activity level, the higher the pain tolerance. https://t.co/yH6kckcBTA https://t.co/BlCXV0VjP2
Dr. John Cush @RheumNow ( View Tweet )
1 year 10 months ago
Korean biologics registry study 526 Ank Spondylitis pts on TNFi > 1yr and tapered; 24.1% experienced flares. Predictors of flare included B27+, inflammatory LBP, psoriasis, SpA Fam Hx, DM, ≥50% TNFi tapering, Dz activity (ASDAS-CRP, BASFI) at tapering https://t.co/Pila2PBlpN https://t.co/WgF9UtfTiR
Dr. John Cush @RheumNow ( View Tweet )
1 year 10 months ago
GEM: Your Clinic Desk needs to be where you can see your patients enter/walk/rise into the clinic. Also pts can see where you work. They learn you & you learn them in ways not gleaned from the exam room https://t.co/WfFqiuztW1
Dr. John Cush @RheumNow ( View Tweet )
1 year 10 months ago
Window of Opportunity in Psoriatic Arthritis A Dutch Early Psoriatic Arthritis cohort study shows that psoriatic arthritis (PsA) patients treated early (referred and diagnosed within in less than 12 weeks) had the best clinical outcomes. https://t.co/mbftcq1dv8 https://t.co/VYNtByK9l0
Dr. John Cush @RheumNow ( View Tweet )
1 year 10 months ago
Secondary Sjogren’s Ups Rheumatoid Arthritis Severity A Swiss observational study has shown that RA patients with concomitant Sjögren’s disease (SjD) are more likely to have a severe RA phenotype, and be less responsive to treatment. https://t.co/CZqLO2GSeM https://t.co/VyLKvUIfJ9
Dr. John Cush @RheumNow ( View Tweet )
1 year 10 months ago
Obesiy (& Visceral abdominal fat) in Ankylosing Spondylitis is assoc w/ worse Dz activity, funct disability, & spinal mobility in study of 74 radiographic axSpA treated with bDMARDs. https://t.co/Z5e9cU62nS https://t.co/fD9lhj085B
Dr. John Cush @RheumNow ( View Tweet )
1 year 10 months ago
High Mortality & complication rates seen in 53 #RA pts presenting w/ Periprosthetic joint infection - 54 PJI w/ avg age 65 yrs (32-88); mortality rate was 19%. Most common was Staphylococci (63%), w/ 20% w/ multiorganism infx & 6 C/S neg https://t.co/Syrm5qPKDQ https://t.co/bnMfMLmFJ7
Dr. John Cush @RheumNow ( View Tweet )
1 year 10 months ago
BIOBADASER registry 1128 RA pts Rx w/ 1st ts/bDMARD, Among the 9.3% w. multimorbidity they noted higher DAS28 dz activity, but no differences in ts/bDMARD retention rates betw those w/ and without multimorbidity https://t.co/hZDpceuOFq https://t.co/pxSg6rKNNr
Dr. John Cush @RheumNow ( View Tweet )
1 year 10 months ago
Korean claims study of #RA & pregnancy (& adverse preg outcomes (APO), shows MTX or LEF use w/in 3 mos of conception assoc w/ incr. in APOs (aOR 2.14-.68). In 5728 preg: 1152 APOs, HCQ most commonly used, DMARD use decreased during preg. https://t.co/fGRZS5ID4A https://t.co/LXaaVYcFsh
Dr. John Cush @RheumNow ( View Tweet )
1 year 10 months ago
Post-COVID MDs spend more time on EHR mostly messaging w/ patients, with a 157% increase from prepandemic average. Each additional patient message was associated with a 2.32-min increase in EHR time per day (P < .001), mostly messaging https://t.co/yfPM3vTmRo https://t.co/XVwC50CH2C
Dr. John Cush @RheumNow ( View Tweet )
1 year 10 months ago
Naysayers & Disrupters Dr. Jack Cush reviews the news and journal reports from the past week - including a few contrary reports on infection, seropositivity and plasmapheresis. https://t.co/tm3V8U7pv4 https://t.co/R8U04urRXg
Dr. John Cush @RheumNow ( View Tweet )
1 year 10 months ago
×